“…Reported attitudes and views of population genomic screening at the provider level are scarce. Many international studies report that non-genetics specialist healthcare providers ( Batra et al, 2002 ; Carroll et al, 2008 ; Menzin et al, 2010 ; Klitzman et al, 2013 ; Hauser et al, 2018 ) feel ill-equipped to discuss the benefits, limitations, and health implications of genetic testing for HBOC, LS ( Hamilton et al, 2017 ; Laforest et al, 2019 ), and FH ( Haga et al, 2019 ; Pang et al, 2020 ; Watts et al, 2021 ). Additional reported barriers to population genomic screening include implementation costs, misinterpretation of results, and the potential for increased patient anxiety ( Shkedi-Rafid et al, 2013 ; De Simone et al, 2021 ).…”